BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wei Z, Chen Z, Zhao Y, Fan F, Xiong W, Song S, Yin Y, Hu J, Yang K, Yang L, Xu B, Ge J. Mononuclear phagocyte system blockade using extracellular vesicles modified with CD47 on membrane surface for myocardial infarction reperfusion injury treatment. Biomaterials 2021;275:121000. [PMID: 34218049 DOI: 10.1016/j.biomaterials.2021.121000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hart DA. What Molecular Recognition Systems Do Mesenchymal Stem Cells/Medicinal Signaling Cells (MSC) Use to Facilitate Cell-Cell and Cell Matrix Interactions? A Review of Evidence and Options. Int J Mol Sci 2021;22:8637. [PMID: 34445341 DOI: 10.3390/ijms22168637] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lai J, Huang C, Guo Y, Rao L. Engineered extracellular vesicles and their mimics in cardiovascular diseases. J Control Release 2022;347:27-43. [PMID: 35508222 DOI: 10.1016/j.jconrel.2022.04.046] [Reference Citation Analysis]
3 Wu X, Jin S, Ding C, Wang Y, He D, Liu Y. Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed. Front Microbiol 2021;12:804813. [PMID: 35046923 DOI: 10.3389/fmicb.2021.804813] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mills JA, Liu F, Jarrett TR, Fletcher NL, Thurecht KJ. Nanoparticle based medicines: approaches for evading and manipulating the mononuclear phagocyte system and potential for clinical translation. Biomater Sci 2022. [PMID: 35419582 DOI: 10.1039/d2bm00181k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Liang X, Niu Z, Galli V, Howe N, Zhao Y, Wiklander OPB, Zheng W, Wiklander RJ, Corso G, Davies C, Hean J, Kyriakopoulou E, Mamand DR, Amin R, Nordin JZ, Gupta D, Andaloussi SE. Extracellular vesicles engineered to bind albumin demonstrate extended circulation time and lymph node accumulation in mouse models. J Extracell Vesicles 2022;11:e12248. [PMID: 35879268 DOI: 10.1002/jev2.12248] [Reference Citation Analysis]
6 Tominaga N. Anti-Cancer Role and Therapeutic Potential of Extracellular Vesicles. Cancers (Basel) 2021;13:6303. [PMID: 34944923 DOI: 10.3390/cancers13246303] [Reference Citation Analysis]
7 Li M, Fang F, Sun M, Zhang Y, Hu M, Zhang J. Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine. Theranostics 2022;12:4879-903. [PMID: 35836815 DOI: 10.7150/thno.72812] [Reference Citation Analysis]
8 Ejigah V, Owoseni O, Bataille-backer P, Ogundipe OD, Fisusi FA, Adesina SK. Approaches to Improve Macromolecule and Nanoparticle Accumulation in the Tumor Microenvironment by the Enhanced Permeability and Retention Effect. Polymers 2022;14:2601. [DOI: 10.3390/polym14132601] [Reference Citation Analysis]
9 Zhang X, Sun Y, Yang R, Liu B, Liu Y, Yang J, Liu W. An injectable mitochondria-targeted nanodrug loaded-hydrogel for restoring mitochondrial function and hierarchically attenuating oxidative stress to reduce myocardial ischemia-reperfusion injury. Biomaterials 2022;287:121656. [DOI: 10.1016/j.biomaterials.2022.121656] [Reference Citation Analysis]
10 Nian W, Fu C. Exosomes in Myocardial Infarction: Therapeutic Potential and Clinical Application. J of Cardiovasc Trans Res . [DOI: 10.1007/s12265-022-10284-3] [Reference Citation Analysis]
11 Sanmartin MC, Borzone FR, Giorello MB, Yannarelli G, Chasseing NA. Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Biological Carriers for Drug Delivery in Cancer Therapy. Front Bioeng Biotechnol 2022;10:882545. [DOI: 10.3389/fbioe.2022.882545] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]